Mount Sinai Depression and Anxiety Center

Mount Sinai Depression and Anxiety Center provides esketamine treatment in Manhattan, New York. It was the first major academic medical institution in New York City to offer Spravato for treatment resistant depression.

Evaluation comes first and goes deep. The team reviews current and past symptoms along with every previous treatment, uses standardized questionnaires, and may add lab work, genetic testing, and brain imaging before recommending anything.

The center works alongside Mount Sinai's Center for Neuromodulation and specialists across psychiatry, neuroscience, and neurology.

Beyond esketamine, options include intensive medication management, cognitive behavioral therapy, group therapy, and TMS. Dr. James Murrough directs the center. It serves Manhattan and the wider New York City region.